Swiss-based manufacturer Haselmeier inked a deal with Common Sensing to develop a smart, connected drug-delivery device for people who use injectable medications.
The companies plan to combine Haselmeier’s subcutaneous injection technology with Common Sensing’s Gocap injector monitor. The product, which will be sold by Haselmeier, will record the time and dose of every injection and other information, like storage temperature, according to the companies.
Get the full story at our sister site, Drug Delivery News.
The post Common Sensing, Haselmeier ink deal to develop connected injection pen appeared first on MassDevice.